{
 "url": "https://etfiq.com/funds/agng/holdings/",
 "section": "funds",
 "title": "AGNG Holdings: All 84 Positions (May 31, 2026) | ETFIQ",
 "description": "All 84 AGNG holdings with weights, as of May 31, 2026. The top 3 are NOVOB 3.79%, LLY 3.58% and Edwards Lifesciences Corporation 3.37%. Free CSV download.",
 "as_of": "May 31, 2026",
 "ticker": "AGNG",
 "fund": "Global X Aging Population ETF",
 "fund_page": "https://etfiq.com/funds/agng",
 "positions": 84,
 "positions_listed_on_page": 84,
 "lead": "AGNG held 84 positions as of May 31, 2026. Novo Nordisk A/S is the largest at 3.79%; the top 10 are 32.1% of the fund.",
 "source": {
  "name": "Form N-PORT filed with the SEC",
  "url": "https://www.sec.gov/Archives/edgar/data/1432353/000204825126006452/primary_doc.xml",
  "document": "the fund’s SEC filing",
  "book_date": "2026-05-31",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Novo Nordisk A/S",
   "ticker": "NOVOB",
   "weight_pct": 3.795,
   "page": "https://etfiq.com/holdings/novob/"
  },
  {
   "rank": 2,
   "holding": "Eli Lilly & Co",
   "ticker": "LLY",
   "weight_pct": 3.581,
   "page": "https://etfiq.com/holdings/lly/"
  },
  {
   "rank": 3,
   "holding": "Edwards Lifesciences Corporation",
   "ticker": null,
   "weight_pct": 3.374,
   "page": "https://etfiq.com/holdings/ew/"
  },
  {
   "rank": 4,
   "holding": "Roche Holding AG",
   "ticker": null,
   "weight_pct": 3.211,
   "page": null
  },
  {
   "rank": 5,
   "holding": "AbbVie Inc",
   "ticker": "ABBV",
   "weight_pct": 3.158,
   "page": "https://etfiq.com/holdings/abbv/"
  },
  {
   "rank": 6,
   "holding": "Welltower Inc",
   "ticker": "WELL",
   "weight_pct": 3.066,
   "page": "https://etfiq.com/holdings/well/"
  },
  {
   "rank": 7,
   "holding": "Ventas Inc",
   "ticker": "VTR",
   "weight_pct": 3.062,
   "page": "https://etfiq.com/holdings/vtr/"
  },
  {
   "rank": 8,
   "holding": "Merck & Co Inc",
   "ticker": "MRK",
   "weight_pct": 2.991,
   "page": "https://etfiq.com/holdings/mrk/"
  },
  {
   "rank": 9,
   "holding": "Bristol-Myers Squibb Co",
   "ticker": "BMY",
   "weight_pct": 2.977,
   "page": "https://etfiq.com/holdings/bmy/"
  },
  {
   "rank": 10,
   "holding": "Amgen Inc.",
   "ticker": null,
   "weight_pct": 2.932,
   "page": "https://etfiq.com/holdings/amgn/"
  },
  {
   "rank": 11,
   "holding": "Johnson & Johnson",
   "ticker": "JNJ",
   "weight_pct": 2.877,
   "page": "https://etfiq.com/holdings/jnj/"
  },
  {
   "rank": 12,
   "holding": "UCB SA",
   "ticker": null,
   "weight_pct": 2.863,
   "page": "https://etfiq.com/holdings/ucb/"
  },
  {
   "rank": 13,
   "holding": "AstraZeneca PLC",
   "ticker": "AZN",
   "weight_pct": 2.798,
   "page": "https://etfiq.com/holdings/azn/"
  },
  {
   "rank": 14,
   "holding": "Stryker Corp",
   "ticker": "SYK",
   "weight_pct": 2.785,
   "page": "https://etfiq.com/holdings/syk/"
  },
  {
   "rank": 15,
   "holding": "Chugai Pharmaceutical Co., Ltd.",
   "ticker": null,
   "weight_pct": 2.782,
   "page": "https://etfiq.com/holdings/4519/"
  },
  {
   "rank": 16,
   "holding": "Sandoz Group AG",
   "ticker": null,
   "weight_pct": 2.617,
   "page": "https://etfiq.com/holdings/sdz/"
  },
  {
   "rank": 17,
   "holding": "Medtronic PLC",
   "ticker": "MDT",
   "weight_pct": 2.599,
   "page": "https://etfiq.com/holdings/mdt/"
  },
  {
   "rank": 18,
   "holding": "Regeneron Pharmaceuticals Inc",
   "ticker": "REGN",
   "weight_pct": 2.479,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 19,
   "holding": "Boston Scientific Corp",
   "ticker": "BSX",
   "weight_pct": 2.44,
   "page": "https://etfiq.com/holdings/bsx/"
  },
  {
   "rank": 20,
   "holding": "Alcon AG",
   "ticker": null,
   "weight_pct": 2.349,
   "page": "https://etfiq.com/holdings/alc/"
  },
  {
   "rank": 21,
   "holding": "BeOne Medicines AG",
   "ticker": "ONC",
   "weight_pct": 2.239,
   "page": "https://etfiq.com/holdings/onc/"
  },
  {
   "rank": 22,
   "holding": "Celltrion, Inc.",
   "ticker": null,
   "weight_pct": 2.096,
   "page": "https://etfiq.com/holdings/068270/"
  },
  {
   "rank": 23,
   "holding": "Dexcom Inc",
   "ticker": "DXCM",
   "weight_pct": 2.011,
   "page": "https://etfiq.com/holdings/dxcm/"
  },
  {
   "rank": 24,
   "holding": "Astellas Pharma Inc.",
   "ticker": null,
   "weight_pct": 1.834,
   "page": "https://etfiq.com/holdings/astellas-pharma/"
  },
  {
   "rank": 25,
   "holding": "United Therapeutics Corp",
   "ticker": "UTHR",
   "weight_pct": 1.726,
   "page": "https://etfiq.com/holdings/uthr/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": 0.266
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/agng/holdings/agng-holdings.csv",
 "json_book": "https://etfiq.com/data/books/agng.json",
 "markdown": "https://etfiq.com/funds/agng/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of AGNG, data as of May 31, 2026. https://etfiq.com/funds/agng/holdings/"
}